The Indian government's procurement process of Covid-19 vaccines caters to both Indian and foreign firms in the following ways:

• The government has opened up the procurement process to allow both Indian and foreign firms to participate in the bid to supply vaccines.
• Indian firms such as Serum Institute of India and Bharat Biotech have been given preference and priority over foreign firms.
• However, foreign firms such as Pfizer, Moderna and Johnson & Johnson have also been allowed to supply vaccines to India.
• The government has allowed foreign firms to seek emergency use authorization for their vaccines in India without the need for local clinical trials, which has made it easier for them to participate in the procurement process.
• The pricing for the vaccines is fixed by the government and the same price is offered to both Indian and foreign firms.
• The government has also given advance funding to both Indian and foreign firms to help with the development and manufacturing of vaccines.
In conclusion, the Indian government's procurement process of Covid-19 vaccines has made it possible for both Indian and foreign firms to participate in supplying vaccines to India. The government has provided equal opportunities and support to both local and international firms to ensure that India is able to vaccinate its population as quickly as possible.